Contribution statement AK and SAA contributed to the concept of the study and study design
Content may require purchase if you do not have access.) Article purchase Temporarily unavailable References Ballatori, N, Krance, SM, Notenboom, S, et al
Adalimumab Adalimumab is a fully human monoclonal antibody developed using phage display technology, which targets TNF
Ela ajuda a transportar os cidos graxos para as mitocndrias, onde so queimados para produo de energia
Nu ngn sch cho php, u tin dng liposomal
Its ability to penetrate the BBB, its metabolic stability, and its significant efficacy in restoring cognitive and motor functions in animal models of AD and PD, likely through modulating the HGF/c-Met system, position it as a highly promising therapeutic candidate for these debilitating neurodegenerative diseases [2]